Roche $5.7 Billion Tumor Drug Sales Hinge on Rival Tests

Roche $5.7 Billion Tumor Drug Sales Hinge on Rival Tests

Adrian Moser/Bloomberg

Roche Holding AG made 5.29 billion Swiss francs in sales last year from Herceptin.